Collegium Pharmaceutical, Inc. Common Stock (COLL) is a publicly traded Healthcare sector company. As of July 23, 2026, COLL trades at $34.59 with a market cap of $1.16B and a P/E ratio of 14.70. COLL moved -1.27% today. Year to date, COLL is -25.01%; over the trailing twelve months it is +9.73%. Its 52-week range spans $23.23 to $50.79. Analyst consensus is strong buy with an average price target of $54.00. Rallies surfaces COLL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest COLL news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $34.59 |
| Market Cap | $1.16B |
| P/E Ratio | 14.70 |
| EPS | $2.37 |
| Dividend Yield | 0.00% |
| 52-Week High | $50.79 |
| 52-Week Low | $23.23 |
| Volume | 27.67K |
| Avg Volume | 0 |
| Revenue (TTM) | $796.33M |
| Net Income | $74.95M |
| Gross Margin | 60.68% |
5 analysts cover COLL: 0 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $54.00.